The DOI matches its Crossref record; 65 of the 70 references it cites were found in a registry or an index.
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Open accessAbstract
p21CIP1/WAF1 is a CDK inhibitor regulated by the tumor suppressor p53 and is hypothesized to mediate G1 arrest. p53 has been suggested to derive anti-oncogenic properties from this relationship. To test these notions, we created mice lacking p21CIP1/WAF1. They develop normally and (unlike p53-/- mice) have not developed spontaneous malignancies during 7 months of observation. Nonetheless, p21-/- embryonic fibroblasts are significantly deficient in their ability to arrest in G1 in response to DNA damage and nucleotide pool perturbation. p21-/- cells also exhibit a significant growth alteration in vitro, achieving a saturation density as high as that observed in p53-/- cells. In contrast, other aspects of p53 function, such as thymocytic apoptosis and the mitotic spindle checkpoint, appear normal. These results establish the role of p21CIP1/WAF1 in the G1 checkpoint, but suggest that the anti-apoptotic and the anti-oncogenic effects of p53 are more complex.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p21 is required for p53-mediated G1/S146, 147, 148 and also for G2/M cell cycle arrest.149”
From Census and evaluation of p53 target genes (2017) · cites this paper as [148]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Inhibitors of mammalian G1 cyclin-dependent kinases.Preprint
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,242
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Research works printed but not linked: 3
- Jiang, 1994, Induction of differentiation in human promyelocytic HL60 leukemia cells activates p21WAF1/CIP1 expression in the absence of p53, Oncogene, 9, 3397
- Steinman, 1994, Induction of p21 (WAFf1CIPl) during differentiation, Oncogene, 9, 3389
- Strasser, 1993, Eubcl2 transgene facilitates spontaneaous transformation of early pre-B and Ig secreting cells but not T cells, Oncogene, 8, 1
Cited by
Sorted by citations
Items 401–500 of 1,008
Schreiber, M., Muller, W. J., Singh, G., & Graham, F. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202466 · Cited by 145
Mullenders, J., Fabius, A. W. M., Madiredjo, M., Bernards, R., & Beijersbergen, R. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004798 · Cited by 146
Cell cycle regulatory control for uterine stromal cell decidualization in implantation
Das, S. (2009) · Reproduction · doi:10.1530/rep-08-0539 · Cited by 144
ATM kinase: Much more than a DNA damage responsive protein
Guleria, A., & Chandna, S. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.12.009 · Cited by 147
Buzzard, J. J., Wreford, N. G., & Morrison, J. R. (2003) · Endocrinology · doi:10.1210/en.2003-0379 · Cited by 144
Control of E2F activity by p21Waf1/Cip1
Delavaine, L., & Thangue, N. B. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202923 · Cited by 143
Tan, J., Raja, S., Davis, M., Tawfik, O. W., Dey, S. K., & Das, S. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00614-1 · Cited by 142
Wang, Y., Blandino, G., & Givol, D. (1999) · Oncogene · doi:10.1038/sj.onc.1202632 · Cited by 142
Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage
Li, R., Hannon, G. J., Beach, D., & Stillman, B. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00452-9 · Cited by 142
Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression
Mussman, J. G., Horn, H. F., Carroll, P. E., Okuda, M., Tarapore, P., Donehower, L. A., & Fukasawa, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203460 · Cited by 142
Ogasawara, T., Kawaguchi, H., Jinno, S., Hoshi, K., Itaka, K., Takato, T., Nakamura, K., & Okayama, H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6560-6568.2004 · Cited by 140
Choi, E. J. (2007) · Nutrition and Cancer · doi:10.1080/01635580701419030 · Cited by 138
Introduction: p53 – the first twenty years
Oren, M., & Rotter, V. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050265 · Cited by 141
Zupkovitz, G., Grausenburger, R., Brunmeir, R., Senese, S., Tischler, J., Jurkin, J., Rembold, M., Meunier, D., Egger, G., Lagger, S., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01500-09 · Cited by 146
The retinoblastoma gene pathway regulates the postmitotic state of hair cells of the mouse inner ear
Mantela, J., Jiang, Z., Ylikoski, J. S., Fritzsch, B., Zacksenhaus, E., & Pirvola, U. (2005) · Development · doi:10.1242/dev.01834 · Cited by 138
Zhang, X., Sun, H., Danila, D. C., Johnson, S. R., Zhou, Y., Swearingen, B., & Klibanski, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8315 · Cited by 137
The cdk inhibitor p27Xic1 is required for differentiation of primary neurones inXenopus
Vernon, A. E., Devine, C., & Philpott, A. (2002) · Development · doi:10.1242/dev.00193 · Cited by 137
Mitsuuchi, Y., Johnson, S. W., Selvakumaran, M., Williams, S. J., Hamilton, T. C., & Testa, J. R. (2000) · PubMed · Cited by 137
The role of cyclin E in cell proliferation, development and cancer
Keyomarsi, K., & Herliczek, T. W. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_14 · Cited by 135
Takeuchi, S., Takahashi, A., Motoi, N., Yoshimoto, S., Tajima, T., Yamakoshi, K., Hirao, A., Yanagi, S., Fukami, K., Ishikawa, Y., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0801 · Cited by 136
DNA damage induces downregulation of histone gene expression through the G1 checkpoint pathway
Su, C., Gao, G., Schneider, S. M., Helt, C. E., Weiß, C., O’Reilly, M. A., Bohmann, D., & Zhao, J. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600120 · Cited by 135
Pituitary Gland Development and Disease
Davis, S. W., Ellsworth, B. S., Millan, M. I. P., Gergics, P., Schade, V., Foyouzi, N., Brinkmeier, M. L., Mortensen, A. H., & Camper, S. A. (2013) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-416021-7.00001-8 · Cited by 133
Choi, E. J., & Kim, G. (2008) · Phytomedicine · doi:10.1016/j.phymed.2008.04.006 · Cited by 133
Identification of p21 as a Direct Target of EWS-Fli1 Oncogenic Fusion Protein
Nakatani, F., Tanaka, K., Sakimura, R., Matsumoto, Y., Matsunobu, T., Li, X., Hanada, M., Okada, T., & Iwamoto, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211470200 · Cited by 137
Massive Apoptosis of Thymocytes in T-Cell-Deficient Id1 Transgenic Mice
Kim, D.-S., Peng, X.-C., & Sun, X.-H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8240 · Cited by 133
The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells.
Poon, R. Y. C., Chau, M. S., Yamashita, K., & Hunter, T. R. (1997) · PubMed · Cited by 132
The Retinoblastoma Gene: A Prototypic and Multifunctional Tumor Suppressor
Zheng, L., & Lee, W. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5129 · Cited by 133
Mazumdar, T., DeVecchio, J., Agyeman, A., Shi, T., & Houghton, J. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4173 · Cited by 132
Harris, T. E., Albrecht, J. H., Nakanishi, M., & Darlington, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011587200 · Cited by 133
Huang, S., Liu, L. N., Hosoi, H., Dilling, M. B., Shikata, T., & Houghton, P. J. (2001) · PubMed · Cited by 130
Tsg101 Is Essential for Cell Growth, Proliferation, and Cell Survival of Embryonic and Adult Tissues
Wagner, K., Krempler, A., Qi, Y., Park, K.-R., Henry, M. D., Triplett, A. A., Riedlinger, G., Rucker, E. B., & Hennighausen, L. G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.150-162.2003 · Cited by 132
Munsch, D., Watanabe-Fukunaga, R., Bourdon, J.-C., Nagata, S., May, E., Yonish-Rouach, E., & Reisdorf, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3867 · Cited by 131
Combined-Modality Treatment of Solid Tumors Using Radiotherapy and Molecular Targeted Agents
Ma, B. B. Y., Bristow, R. G., Kim, J., & Siu, L. L. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.044 · Cited by 131
Passer, B. J., Nancy-Portebois, V., Amzallag, N., Prieur, S., Cans, C., de Climens, A. R., Fiucci, G., Bouvard, V., Tuynder, M., Susini, L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530298100 · Cited by 134
Noscapine Crosses the Blood-Brain Barrier and Inhibits Glioblastoma Growth
Landen, J. W., Hau, V. S., Wang, M., Davis, T. P., Ciliax, B. J., Wainer, B. H., Meir, E. G. V., Glass, J. D., Joshi, H. C., & Archer, D. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0360 · Cited by 130
Mammalian DNA damage-inducible genes associated with growth arrest and apoptosis
Smith, M. L., & Fornace, A. J. (1996) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/s0165-1110(96)90043-3 · Cited by 129
Tan, J. Y., Zhuang, L., Leong, H. S., Iyer, N. G., Liu, E. T., & Yu, Q. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1226 · Cited by 132
Johnson, T. M., Hammond, E. M., Giaccia, A. J., & Attardi, L. D. (2005) · Nature Genetics · doi:10.1038/ng1498 · Cited by 134
Zhang, J., Wei, Q., Zhao, X., & Paterson, B. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.926 · Cited by 130
Tumor suppressor p53 and its gain-of-function mutants in cancer
Liu, J., Zhang, C., & Feng, Z. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt144 · Cited by 133
Phosphorylation of p21 in G2/M Promotes Cyclin B-Cdc2 Kinase Activity
Dash, B. C., & El‐Deiry, W. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.3364-3387.2005 · Cited by 129
Demers, G. W., Espling, E., Harry, J. B., Etscheid, B. G., & Galloway, D. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.6862-6869.1996 · Cited by 129
A DNA Damage Checkpoint Meets the Cell Cycle Engine
Weinert, T. A. (1997) · Science · doi:10.1126/science.277.5331.1450 · Cited by 129
Inactivation of mouse Hus1 results in genomic instability and impaired responses to genotoxic stressPreprint
Weiss, R. S., Enoch, T., & Leder, P. (2000) · Genes & Development · doi:10.1101/gad.14.15.1886 · Cited by 130
Self-citationFranklin, D. S., & Xiong, Y. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.10.1587 · Cited by 130
Hsu, C. A., Rishi, A. K., Su-Li, X., Gerald, T. M., Dawson, M. I., Schiffer, C. A., Reichert, U., Shroot, B., Poirier, G. G., & Fontana, J. A. (1997) · Blood · doi:10.1182/blood.v89.12.4470 · Cited by 128
E2A and HEB Are Required to Block Thymocyte Proliferation Prior to Pre-TCR Expression
Wojciechowski, J., Lai, A. Y., Kondo, M., & Zhuang, Y. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5717 · Cited by 126
Terminal dendritic sprouting and reactive synaptogenesis in the postnatal organ of Corti in culture
Sobkowicz, H. M., August, B. K., Slapnick, S. M., & Luthy, D. F. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980727)397:2 · Cited by 9
Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23
MacPherson, D., Kim, J., Kim, T., Rhee, B. K., van Oostrom, C. T., DiTullio, R. A., Venere, M., Halazonetis, T. D., Bronson, R., de Vries, A., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600363 · Cited by 124
Hirota, Y., Cha, J., Yoshie, M., Daikoku, T., & Dey, S. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108180108 · Cited by 125
Cha, H. H., Cram, E. J., Wang, E. C., Huang, A. J., Kasler, H. G., & Firestone, G. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.1998 · Cited by 125
The lack of a functional p21 WAF1/CIP1 gene ameliorates progression to chronic renal failure
Megyesi, J. K., Price, P. M., Tamayo, E. H., & Safirstein, R. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10830 · Cited by 125
Induction of p21 WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16 INK4a
Mitra, J., Dai, C. Y., Somasundaram, K., El‐Deiry, W. S., Satyamoorthy, K., Herlyn, M., & Enders, G. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3916 · Cited by 125
Brady, H. J. M., Salomons, G. S., Bobeldijk, R. C., & Berns, A. J. M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00463.x · Cited by 125
Identification of genes induced by BRCA1 in breast cancer cells
Atalay, A., Crook, T. J., Öztürk, M., & Yuluğ, I. G. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02751-1 · Cited by 126
Pérez‐Martínez, L., & Jaworski, D. M. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5066-04.2005 · Cited by 129
Different impact of p53 and p21 on the radiation response of mouse tissues
Komarova, E. A., Christov, K. T., Faerman, A., & Gudkov, A. V. (2000) · Oncogene · doi:10.1038/sj.onc.1203717 · Cited by 126
Zlotta, A. R., Noël, J., Fayt, I., Drowart, A., Vooren, J. V., Huygen, K., Simon, J., & Schulman, C. C. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61770-1 · Cited by 124
Stat Proteins Control Lymphocyte Proliferation by Regulating p27Kip1 Expression
Kaplan, M. H., Daniel, C., Schindler, U., & Grusby, M. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.1996 · Cited by 123
Asymmetric Cell Kinetics Genes: The Key to Expansion of Adult Stem Cells in Culture
Sherley, J. L. (2002) · Stem Cells · doi:10.1634/stemcells.20-6-561 · Cited by 124
Mechanisms of T-Cell Activation by Human T-Cell Lymphotropic Virus Type I
Höllsberg, P. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.2.308-333.1999 · Cited by 123
Romanov, V. S., Поспелов, В. А., & Pospelova, T. V. (2012) · Biochemistry (Moscow) · doi:10.1134/s000629791206003x · Cited by 122
DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking to facilitate repair
O’Reilly, M. A. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.2.l291 · Cited by 122
p53 downstream targets and chemosensitivity
Sax, J. K., & El‐Deiry, W. S. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401227 · Cited by 122
HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice
Wang, Y., Cui, F., Lv, Y., Li, C., Xu, X., Deng, C., Wang, D., Sun, Y., Hu, G., Lang, Z.-W., et al. (2004) · Hepatology · doi:10.1002/hep.20076 · Cited by 121
Self-citationPiekorz, R. P., Hoffmeyer, A., Duntsch, C. D., McKay, C., Nakajima, H., Sexl, V., Snyder, L., Rehg, J. E., & Ihle, J. N. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.653 · Cited by 121
Serrated Pathway and APC (Conventional)-Type Colorectal Polyps
Goldstein, N. S. (2005) · American Journal of Clinical Pathology · doi:10.1309/87bd0c6ucgug236j · Cited by 121
Roles of BRCA1 in centrosome duplication
Deng, C. (2002) · Oncogene · doi:10.1038/sj.onc.1205713 · Cited by 120
Self-citationPartial rescue of the prophase I defects of Atm-deficient mice by p53 and p21 null alleles
Barlow, C., Liyanage, M., Møens, P. B., Deng, C., Ried, T., & Wynshaw-Boris, A. J. (1997) · Nature Genetics · doi:10.1038/ng1297-462 · Cited by 120
Self-citationTakubo, K., Ohmura, M., Azuma, M., Nagamatsu, G., Yamada, W., Arai, F., Hirao, A., & Suda, T. (2008) · Cell stem cell · doi:10.1016/j.stem.2007.10.023 · Cited by 122
The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression
Zou, T., & Lin, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115754 · Cited by 124
Nuclear factor kappaB subunits induce epithelial cell growth arrest.
Seitz, C. S., Deng, H., Hinata, K., Lin, Q., & Khavari, P. A. (2000) · PubMed · Cited by 119
RhoE Inhibits Cell Cycle Progression and Ras-Induced Transformation
Villalonga, P., Guasch, R. M., Riento, K., & Ridley, A. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.7829-7840.2004 · Cited by 120
The Metastasis-Associated Gene Prl-3 Is a p53 Target Involved in Cell-Cycle Regulation
Basak, S., Jacobs, S. B. R., Krieg, A. J., Pathak, N., Zeng, Q., Kaldis, P., Giaccia, A. J., & Attardi, L. D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.002 · Cited by 128
A new pathway for mitogen-dependent Cdk2 regulation uncovered in p27Kip1-deficient cells
Coats, S., Whyte, P., Fero, M. L., Lacy, S. E., Chung, G., Randel, E., Firpo, E. J., & Roberts, J. M. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80086-4 · Cited by 117
Akt-1 Expression Level Regulates CNS Precursors
Sinor, A. D., & Lillien, L. E. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1470-04.2004 · Cited by 117
The antiangiogenic agent TNP-470 requires p53 and p21 CIP/WAF for endothelial cell growth arrest
Yeh, J.-R. J., Mohan, R., & Crews, C. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12782 · Cited by 120
Cell cycle inhibitors in normal and tumor stem cells.
Cheng, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207945 · Cited by 117
ei24 , a p53 Response Gene Involved in Growth Suppression and Apoptosis
Gu, Z., Flemington, C., Chittenden, T., & Zambetti, G. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.233-241.2000 · Cited by 118
Fox, D. K., Ebert, S. M., Bongers, K. S., Dyle, M. C., Bullard, S. A., Dierdorff, J. M., Kunkel, S. D., & Adams, C. M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00010.2014 · Cited by 125
p53 and p21 Form an Inducible Barrier that Protects Cells against Cyclin E-cdk2 Deregulation
Minella, A. C., Swanger, J., Bryant, E. M., Welcker, M., Hwang, H. C., & Clurman, B. E. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01225-3 · Cited by 119
Glick, A. B., Weinberg, W. C., Wu, I. H., Quan, W., & Yuspa, S. H. (1996) · PubMed · Cited by 117
Ghiani, C. A., Eisen, A. M., Yuan, X. Q., DePinho, R. A., McBain, C. J., & Gallo, V. (1999) · Development · doi:10.1242/dev.126.5.1077 · Cited by 117
Senescent Phenotype Can Be Reversed by Reduction of Caveolin Status
Cho, K. A., Ryu, S. J., Park, J., Jang, I., Ahn, J. S., Kim, K. T., & Park, S. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208105200 · Cited by 116
Sepp‐Lorenzino, L., & Rosen, N. X. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20243 · Cited by 117
Resnick‐Silverman, L., Clair, S. S., Maurer, M., Zhao, K., & Manfredi, J. J. (1998) · Genes & Development · doi:10.1101/gad.12.14.2102 · Cited by 117
The G2 Checkpoint Is Maintained by Redundant Pathways
Passalaris, T. M., Benanti, J. A., Gewin, L., Kiyono, T., & Galloway, D. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5872 · Cited by 116
Chao, C., Wu, Z., Mazur, S. J., Borges, H. L., Rossi, M., Lin, T., Wang, J. Y. J., Anderson, C. W., Appella, E., & Xu, Y. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00062-06 · Cited by 119
Transcriptional Regulation during p21/-induced Apoptosis in Human Ovarian Cancer Cells
Wu, Q. J., Kirschmeier, P. T., Hockenberry, T., Yang, T., Brassard, D., Wang, L., McClanahan, T., Black, S., Rizzi, G., Musco, M. L., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204962200 · Cited by 116
Cox, L. S. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199710)183:2 · Cited by 115
MiRNA-34 intrinsically links p53 tumor suppressor and Wnt signaling
Cha, Y. H., Kim, N. H., Park, C., Lee, I., Kim, H. S., & Yook, J. I. (2012) · Cell Cycle · doi:10.4161/cc.19618 · Cited by 115
Less understood issues: p21Cip1 in mitosis and its therapeutic potential
Kreis, N., Louwen, F., & Yuan, J. (2014) · Oncogene · doi:10.1038/onc.2014.133 · Cited by 116
Tundo, G. R., Sbardella, D., Santoro, A. M., Coletta, A., Oddone, F., Grasso, G., Milardi, D., Lacal, P. M., Marini, S., Purrello, R., et al. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107579 · Cited by 120
Starheim, K. K., Arnesen, T., Gromyko, D., Ryningen, A., Varhaug, J. E., & Lillehaug, J. R. (2008) · Biochemical Journal · doi:10.1042/bj20080658 · Cited by 115
Cell cycle regulators and hematopoiesis
Steinman, R. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205325 · Cited by 116
CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication
Mansilla, S. F., De La Vega, M. B., Calzetta, N. L., Siri, S. O., & Gottifredi, V. (2020) · Genes · doi:10.3390/genes11060593 · Cited by 114
Lunyak, V. V., Amaro-Ortiz, A., & Gaur, M. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00220 · Cited by 119
Death squads enlisted by the tumour suppressor p53
Michalak, E. M., Villunger, A., Erlacher, M., & Strasser, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.183 · Cited by 116
GATA-6 Induces p21Cip1 Expression and G1Cell Cycle Arrest
Perlman, H., Suzuki, E., Simonson, M. S., Smith, R. C., & Walsh, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13713 · Cited by 114
Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development.
Zindy, F., Soares, H. D., Herzog, K., Morgan, J., Sherr, C. J., & Roussel, M. F. (1997) · PubMed · Cited by 114
Metadata
- Authors
- Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P.
- Affiliations
- Baylor College of Medicine (US)
- Howard Hughes Medical Institute (US)
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1995-08
- Volume
- 82
- Issue
- 4
- Pages
- 675-684
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2044057392
- Cited by
- 2,113
- References
- 70
- Citations by year
- 2026: 20 · 2025: 20 · 2024: 32 · 2023: 32 · 2022: 34 · 2021: 40 · 2020: 38 · 2019: 40 · 2018: 43 · 2017: 36 · 2016: 37 · 2015: 34 · 2014: 57 · 2013: 39 · 2012: 65
- FWCI
- 61.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Institute on Aging (AG11085, R01AG011085)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p21, p53, G1/S checkpoint, cyclin-dependent kinase inhibitors, DNA damage response, embryonic fibroblasts, cell growth, thymocyte apoptosis, mitotic spindle checkpoint, tumor suppression
- MeSH terms
- Animals, Base Sequence, Cell Differentiation, Cell Division, Cell Line, DNA, DNA Damage, Spindle Apparatus, Molecular Sequence Data, Neoplasms, Experimental, Genes, p53, Tumor Suppressor Protein p53, G1 Phase, Cyclins, Apoptosis, Cyclin-Dependent Kinase Inhibitor p21, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review